300725 PharmaBlock Sciences
- 34.98
- -1.32-3.64%
PharmaBlock Sciences News
Yakushi Technology: Announcement on the allocation of equity and adjustment of convertible debt-to-stock conversion prices in 2022
Yakushi Technology: An indicative announcement that Yakushi convertible bonds may trigger a downward revision of the conversion price conditions
Yakushi Technology: An indicative announcement that Yakushi convertible bonds may trigger a downward revision of the conversion price conditions
Yakushi Technology: An indicative announcement that Yakushi convertible bonds may trigger a downward revision of the conversion price conditions
Yakushi Technology: 2021 Annual Equity Distribution Implementation Notice
Pharmaceutical Technology: Announcement on the acquisition of 46.07% of the shares of Zhejiang Huishi Pharmaceutical Co., Ltd. to complete the industrial and commercial changes
Yakushi Technology: Prospectus Notice for Issuance of Convertible Corporate Bonds to Unspecified Targets
Yakushi Technology: Online Roadshow Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets
Pharmaceutical Stone Technology: 1. Responses from issuers and sponsors to the implementation letter of feedback on the issuance registration process (revised draft)
Medicinal Stone Technology: 3 Supplemental Legal Opinions (4)
Pharmaceutical Stone Technology: 2 Accountants' Response to the Issuance and Registration Process Feedback Implementation Letter
Pharmaceutical Stone Technology: Responses from issuers and sponsors to the implementation letter of feedback on the issuance registration process (revised draft)
Pharmaceutical Stone Technology: Prompt Notice on Responding to the “Issuance and Registration Process Feedback Implementation Letter”
Medicinal Stone Technology: Issuance and Registration Process Feedback Implementation Letter
Pharmaceutical Stone Technology: Announcement on the application for issuing convertible corporate bonds to unspecified targets and approved by the Shenzhen Stock Exchange GEM Listing Committee
Medicinal Stone Technology: Application Guide (Second Revised Draft)
Yakushi Technology: IPO Sponsorship Letter
Yakushi Technology: Securities Issuance Sponsorship
Pharmaceutical Stone Technology: Response of Nanjing Pharmaceutical Stone Technology Co., Ltd. and Huatai United Securities Co., Ltd. on the review inquiry letter of Nanjing Pharmaceutical Stone Technology Co., Ltd.'s application to issue convertible corpo
Pharmaceutical Stone Technology: Prompt Notice on Response to the Audit Inquiry Letter on the Application for Issuance of Convertible Corporate Bonds to Unspecified Targets (Second Revised Draft)
Analysis
Price Target
No Data
No Data